GMED
Globus Medical·NYSE
--
--(--)
--
--(--)
6.62 / 10
Outperform
Analyst consensus is 100% bullish (33% Strong Buy, 67% Buy) from three firms, with mixed historical returns. Fund‑flow score 7.78/10 indicates good liquidity; small and large investors show positive inflows despite an overall negative trend.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
33%
Buy
67%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-25
InstitutionNeedham
Times predicted3
Historical Win Rate33.3%
What is the analyst consensus for GMED?
- GMED holds a Bullish analyst rating, with 67% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.62/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
